Diversify Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.82M Buy
+13,919
New +$1.83M 0.03% 443
2026
Q1
– Sell
-4,533
Closed -$566K – 466
2025
Q4
$566K Buy
4,533
+569
+14% +$69.1K 0.02% 568
2025
Q3
$484K Sell
3,964
-332
-8% -$37.7K 0.02% 575
2025
Q2
$516K Buy
4,296
+674
+19% +$71.7K 0.02% 524
2025
Q1
$377K Buy
3,622
+1,109
+44% +$114K 0.02% 422
2024
Q4
$226K Sell
2,513
-491
-16% -$44.2K 0.01% 563
2024
Q3
$265K Sell
3,004
-210
-7% -$16K 0.01% 529
2024
Q2
$218K Sell
3,214
-1,126
-26% -$75.1K 0.01% 589
2024
Q1
$316K Buy
+4,340
New +$334K 0.02% 527

Other funds holding GILD

Diversify Advisory Services's GILD Position: Q2 2026 in Review

Diversify Advisory Services opened a new position in Gilead Sciences (GILD) in Q2 2026: 13,919 shares worth $1.82M. The stake represents 0.03% of the portfolio and ranks #443 among its holdings. This is a return to the name: Diversify Advisory Services previously reported a position in GILD as recently as Q4 2025.

Diversify Advisory Services first reported a position in GILD in Q1 2024 and has held it in 9 quarters since. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Diversify Advisory Services held 13,919 shares of Gilead Sciences worth $1.82M as of Q2 2026.
  • Gilead Sciences was a new Diversify Advisory Services position in Q2 2026.
  • Gilead Sciences made up 0.03% of Diversify Advisory Services's portfolio in Q2 2026, its #443 holding.
  • Diversify Advisory Services first reported a position in Gilead Sciences in Q1 2024 and has held it in 9 quarters since.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.